R Zhou, S Chen, Q Wu, L Liu, Y Wang, Y Mo, Z Zeng… - Cancer letters, 2023 - Elsevier
In recent years, there have been multiple breakthroughs in cancer immunotherapy, with
immune checkpoint inhibitors becoming the most promising treatment strategy. However …